Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung cancer immunotherapy: progress, pitfalls, and promises
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 476

Showing 26-50 of 476 citing articles:

Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 7
Circular RNAs: novel actors of Wnt signaling pathway in lung cancer progression.
Mina Alimohammadi, Yasaman Gholinezhad, Vahide Mousavi, et al.
PubMed (2023) Vol. 22, pp. 645-669
Closed Access | Times Cited: 20
Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing
Yan Zhou, Yizhen Guo, Maoxin Ran, et al.
Cancer Letters (2023) Vol. 577, pp. 216425-216425
Closed Access | Times Cited: 19
Listeria monocytogenes: a promising vector for tumor immunotherapy
Yi-Dan Ding, Lin-Zhen Shu, Rui-Shan He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Immunotherapeutic treatment of lung cancer and bone metastasis with a mPLA/mRNA tumor vaccine
Shijie Ma, Xiaolong Li, Yaping Mai, et al.
Acta Biomaterialia (2023) Vol. 169, pp. 489-499
Open Access | Times Cited: 16
Tumor-associated macrophages in non-small-cell lung cancer: From treatment resistance mechanisms to therapeutic targets
Zhenjun Huang, Ziqi Xiao, Li‐Qing Yu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104284-104284
Open Access | Times Cited: 6
A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis
Sumel Ashique, Neeraj Mishra, Ashish Garg, et al.
Archivos de Bronconeumología (2024) Vol. 60, pp. S46-S58
Closed Access | Times Cited: 6
Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy
Komal Kumari, Amarnath Singh, Archana Chaudhary, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 498-498
Open Access | Times Cited: 6
Suppression of PERK/eIF2α/CHOP pathway enhances oridonin-induced apoptosis by inhibiting autophagy in Small-Cell lung cancer cells
Linhao Xu, Yu-Xin Jiang, Yanli Bi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116684-116684
Open Access | Times Cited: 6
Lipid-Laden Macrophages in Pulmonary Diseases
Yin Zhu, Dooyoung Choi, Payaningal R. Somanath, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 889-889
Open Access | Times Cited: 6
Thiosemicarbazone Mixed-Valence Cu(I/II) Complex against Lung Adenocarcinoma Cells through Multiple Pathways Involving Cuproptosis
Aili Li, Kai Huang, Wei‐Ping Pan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9091-9103
Closed Access | Times Cited: 6
Recent development of Schiff-base metal complexes as therapeutic agents for lung cancer
Ming Jiang, Xiaoling Su, Xuwei Zhong, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139403-139403
Closed Access | Times Cited: 6
Gasdermins: a dual role in pyroptosis and tumor immunity
Jiayi Yang, Jingting Jiang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Cutting-Edge Therapies for Lung Cancer
Anita Silas La’ah, Shih-Hwa Chiou
(2024)
Open Access | Times Cited: 5
A coumarin-furoxan hybrid as novel nitric oxide donor induced cell apoptosis and ferroptosis in NSCLC by promoting S-nitrosylation of STAT3 and negative regulation of JAK2-STAT3 pathway
Fan Cao, Mengru Li, Weijie Wang, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116068-116068
Closed Access | Times Cited: 5
Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy
Yijiang Jia, Renbo Jia, Ayijiang Taledaohan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 335-335
Open Access | Times Cited: 5
Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer
Linxiang Zhang, Xueying Zhang, Yanbin Shi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Dual molecule targeting HDAC6 leads to intratumoral CD4+ cytotoxic lymphocytes recruitment through MHC-II upregulation on lung cancer cells
Sarah Ducellier, Mélanie Demeules, Boris Letribot, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e007588-e007588
Open Access | Times Cited: 5
Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy
Zichen Zhong, Wen Deng, Jian Wu, et al.
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8708-8738
Closed Access | Times Cited: 5
Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway
Weilin Liao, Ren Zhang, Geer Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116832-116832
Open Access | Times Cited: 5
CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer
Guanchao Ye, Guangyao Wu, Chun‐yang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Targeted therapy of non-small cell lung cancer: mechanisms and clinical trials
Le Yu, Ruoyi Yang, Long Zeng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Protein Coronation-Induced Cancer Staging-Dependent Multilevel Cytotoxicity: An All-Humanized Study in Blood Vessel Organoids
Chan Wang, Yingyi Quan, Jiang Jiang, et al.
ACS Nano (2025)
Closed Access
B7-H3 regulates HK2 expression and promotes the PI3K/AKT/mTOR pathway
Shiyang Han, Yuantao Wu, Yan Zhang, et al.
Research Square (Research Square) (2025)
Open Access
A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors
Yuncheng Bei, Ying-Wen Huang, Nandie Wu, et al.
EMBO Molecular Medicine (2025)
Open Access

Scroll to top